326 related articles for article (PubMed ID: 34202941)
1. Evaluation of Microalgae Antiviral Activity and Their Bioactive Compounds.
Carbone DA; Pellone P; Lubritto C; Ciniglia C
Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34202941
[TBL] [Abstract][Full Text] [Related]
2. Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19.
Raihan T; Rabbee MF; Roy P; Choudhury S; Baek KH; Azad AK
Front Mol Biosci; 2021; 8():732256. PubMed ID: 34557521
[TBL] [Abstract][Full Text] [Related]
3. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
[TBL] [Abstract][Full Text] [Related]
4. Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants.
Dehghani J; Movafeghi A; Mathieu-Rivet E; Mati-Baouche N; Calbo S; Lerouge P; Bardor M
Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354980
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Activities of Algal-Based Sulfated Polysaccharides.
Panggabean JA; Adiguna SP; Rahmawati SI; Ahmadi P; Zainuddin EN; Bayu A; Putra MY
Molecules; 2022 Feb; 27(4):. PubMed ID: 35208968
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals.
Rosales-Mendoza S; García-Silva I; González-Ortega O; Sandoval-Vargas JM; Malla A; Vimolmangkang S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32899754
[TBL] [Abstract][Full Text] [Related]
7.
Ambrosino A; Chianese A; Zannella C; Piccolella S; Pacifico S; Giugliano R; Franci G; De Natale A; Pollio A; Pinto G; De Filippis A; Galdiero M
Mar Drugs; 2023 Jun; 21(7):. PubMed ID: 37504915
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the bio-application of microalgae-derived biochemical metabolites and development trends of photobioreactor-based culture systems.
Khaligh SF; Asoodeh A
3 Biotech; 2022 Oct; 12(10):260. PubMed ID: 36072963
[TBL] [Abstract][Full Text] [Related]
9. The nanomolar affinity of C-phycocyanin from virtual screening of microalgal bioactive as potential ACE2 inhibitor for COVID-19 therapy.
Prasetiya FS; Destiarani W; Nuwarda RF; Rohmatulloh FG; Natalia W; Novianti MT; Ramdani T; Agung MUK; Arsad S; Sari LA; Pitriani P; Suryanti S; Gumilar G; Mouget JL; Yusuf M
J King Saud Univ Sci; 2023 Apr; 35(3):102533. PubMed ID: 36624782
[TBL] [Abstract][Full Text] [Related]
10. Microalgae as feedstock for bioactive polysaccharides.
Tounsi L; Hentati F; Ben Hlima H; Barkallah M; Smaoui S; Fendri I; Michaud P; Abdelkafi S
Int J Biol Macromol; 2022 Nov; 221():1238-1250. PubMed ID: 36067848
[TBL] [Abstract][Full Text] [Related]
11. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.
Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI
Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998
[TBL] [Abstract][Full Text] [Related]
12. State-of-the-Art Extraction Methodologies for Bioactive Compounds from Algal Biome to Meet Bio-Economy Challenges and Opportunities.
Sosa-Hernández JE; Escobedo-Avellaneda Z; Iqbal HMN; Welti-Chanes J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30424551
[TBL] [Abstract][Full Text] [Related]
13. Biologically active compounds from marine organisms in the strategies for combating coronaviruses.
Zaporozhets TS; Besednova NN
AIMS Microbiol; 2020; 6(4):470-494. PubMed ID: 33364539
[TBL] [Abstract][Full Text] [Related]
14. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
[TBL] [Abstract][Full Text] [Related]
15. Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies.
Okechukwu QN; Adepoju FO; Kanwugu ON; Adadi P; Serrano-Aroca Á; Uversky VN; Okpala COR
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543114
[TBL] [Abstract][Full Text] [Related]
16. Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses.
Siddiqui AJ; Danciu C; Ashraf SA; Moin A; Singh R; Alreshidi M; Patel M; Jahan S; Kumar S; Alkhinjar MIM; Badraoui R; Snoussi M; Adnan M
Plants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967179
[TBL] [Abstract][Full Text] [Related]
17. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharides and Their Derivatives as Potential Antiviral Molecules.
Claus-Desbonnet H; Nikly E; Nalbantova V; Karcheva-Bahchevanska D; Ivanova S; Pierre G; Benbassat N; Katsarov P; Michaud P; Lukova P; Delattre C
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216019
[TBL] [Abstract][Full Text] [Related]
19. Bioactive compounds by microalgae and potentials for the management of some human disease conditions.
Eze CN; Onyejiaka CK; Ihim SA; Ayoka TO; Aduba CC; Ndukwe JK; Nwaiwu O; Onyeaka H
AIMS Microbiol; 2023; 9(1):55-74. PubMed ID: 36891530
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
